Medical Tech News - Aethlon Medical (NASDAQ: AEMD) to Present New Pre-Clinical Data on Long COVID and Post-Acute Infection Syndromes Poste ...

Clinicians and researchers have observed certain personality traits in many people living with ME/CFS and long Covid. Could they help some people to unravel their illness?

High-achieving women often look unstoppable—until they hit burnout and lose sight of who they are. Here's how they can build ...

PYLARIFY has made a profound impact on the lives of patients battling prostate cancer. It is the number one ordered PSMA PET imaging agent in the U.S., and is a proven diagnostic backed by real-world ...

The diabetic nephropathy market is driven by the growing burden of diabetes and the increasing demand for effective treatments for kidney disease. Advances in therapeutics, including new drug classes ...

Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that an abstract has been accepted for ...

ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod; RHO data show efgartigimod achieved susta ...

That same study indicated 62% of remote workers would quit rather than return to an office, while a Moodle study found 66 percent of U.S. employees reported being burned out in 2025, and Talker ...

Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCstm) to profoundly improve people's lives ...

Is “luxury fatigue” here to stay? Despite cautious optimism, the luxury goods sector faces another challenging year with limited sales growth and margin recovery expected in 2025. Discover the key ...

Extended follow-up data from the CheckMate 274 trial have further solidified adjuvant nivolumab’s position as a standard of ...